ArticleTobacco prevention & cessation2026
Predictors of cigarette discontinuation and reduction among adults never planning to quit smoking: Longitudinal findings from the U.S. Population Assessment of Tobacco and Health (PATH) study, 2014/15-2021.
Article in Tobacco prevention & cessation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Introduction: E-cigarettes have increased in use prevalence among adults who smoke cigarettes. However, the population-based literature on e-cigarette use and smoking cessation largely still focuses on those planning or attempting to quit smoking. We evaluated predictors of cigarette discontinuation or reduction among adults not planning to ever quit smoking. Methods: We conducted secondary data analyses using the Population Assessment of Tobacco and Health (PATH) Study (2014-2021; Waves 2-6) cohort data collected in the United States. Data were collected using audio computer-assisted in-person or telephone self-interviews. Participants were aged ≥21 years who smoked cigarettes every day, did not plan to ever quit smoking, and did not use e-cigarettes at baseline assessment. Predictors were previous quit attempt, quitting interest, nicotine dependence, cigarette pack-years, e-cigarette uptake (none, non-daily, daily uptake), e-cigarette flavor (tobacco, menthol/mint, fruit/sweet/other, combination flavors), e-cigarette device type (disposable, cartridge, tank/mod). Outcomes were cigarette discontinuation (from daily to no smoking) and cigarette reduction (from daily to non-daily smoking) among those who did not discontinue smoking. Weighted and adjusted generalized estimating equation logistic regression analyses were conducted. Results: Assessment in 2018/19-2021 (vs 2014/15-2015/16) was associated with higher odds of cigarette reduction (adjusted odds ratio, AOR=2.32; 95% CI: 1.01-5.36). Higher nicotine dependence (vs lower) was associated with lower odds of cigarette reduction (2.3% vs 6.7%, AOR=0.48; 95% CI: 0.25-0.90). Uptake of daily e-cigarette use (vs no uptake) was associated with reducing or discontinuing cigarette smoking (53.5% vs 10.0%, AOR=14.58; 95% CI: 5.99-35.50); the rate of daily e-cigarette uptake was 2%. Conclusions: Uptake of daily e-cigarette use was associated with cigarette reduction/discontinuation among people who smoked daily and did not plan to ever quit. Findings add to growing evidence on the role of e-cigarettes in moving adults who smoke down the continuum of risk, particularly among an understudied population at high risk of smoking-attributable morbidity and mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.